Verastem | VSTM - Beneficio Operativo





Beneficio Operativo Cambio Fecha
AbbVie USD 4.73B 1.08B 2026-03
Alaunos Therapeutics USD -1.19M 148K 2025-09
AstraZeneca USD 7.11B 4.14B 2026-03
Curis USD -7.88M 4.63M 2025-12
Cytokinetics USD -181.23M 2.86M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Incyte USD 324.17M 59.7M 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.99B 340M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
TG Therapeutics USD 34.8M 15.7M 2026-03
Verastem USD -41.48M 23.2M 2025-12